XM does not provide services to residents of the United States of America.

UK budget to give health service huge boost, Reeves says



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UK budget to give health service huge boost, Reeves says</title></head><body>

LONDON, Oct 28 (Reuters) -Britain's finance minister Rachel Reeves will announce billions of pounds in funding for the National Health Service (NHS) in Wednesday's budget that will go towards buying new equipment for hospitals and increasing the number of operations.

Prime Minister Keir Starmer has said tax rises will be necessary to rebuild Britain's public services, pledging no return to austerity despite a difficult fiscal inheritance after Labour won a July election.

"I am putting an end to the neglect and under investment (the NHS) has seen for over a decade now," Reeves said on Monday.

"We will be known as the government that took the NHS from its worst crisis in its history, got it back on its feet again and made it fit for the bright future ahead of it."

The finance ministry said there would be 1.5 billion pounds ($1.95 billion) for new surgical hubs and scanners, and 70 million pounds for radiotherapy machines.

It said there would be enough funding to deliver an extra 40,000 elective appointments a week, including 1.8 billion pounds invested by the government since July.

Reeves will announce the final figure on Wednesday.

The state-run NHS has endured some of its hardest winters recently as it struggled to cope with backlogs in elective procedures delayed by COVID and industrial action.

Starmer has promised to deliver a 10-year plan to fix the NHS in England, after an independent report said it was in critical condition.

He has agreed pay deals with health workers, ending a series of strikes the previous Conservative government blamed for extending waiting lists.

The finance ministry said the extra funding would help the NHS meet a commitment that 92% of people wait less than 18 weeks to start treatment.

The British government runs the health service in England, and it is a devolved area of policy in Scotland, Wales and Northern Ireland.


($1 = 0.7705 pounds)



Reporting by Alistair Smout, editing by Ed Osmond

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.